v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series B preferred stock
Preferred Stock
Series B preferred stock
Common Stock
Series B preferred stock
Additional Paid-In Capital
Series B preferred stock
Accumulated Deficit
Series B preferred stock
Series C preferred stock
Preferred Stock
Series C preferred stock
Common Stock
Series C preferred stock
Additional Paid-In Capital
Series C preferred stock
Accumulated Deficit
Series C preferred stock
Series D preferred stock
Preferred Stock
Series D preferred stock
Common Stock
Series D preferred stock
Additional Paid-In Capital
Series D preferred stock
Accumulated Deficit
Series D preferred stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024                               $ 10 $ 155,452 $ (148,107) $ 7,355
Balance (in Shares) at Dec. 31, 2024                               928,911      
Stock-based compensation                               1,079 1,079
Issuance of common stock                               1,606 1,606
Issuance of common stock (in Shares)                                 198,391      
Net loss                               (8,403) (8,403)
Balance at Jun. 30, 2025                               $ 10 158,137 (156,510) 1,637
Balance (in Shares) at Jun. 30, 2025                               1,127,302      
Balance at Mar. 31, 2025                               $ 10 156,509 (153,285) 3,234
Balance (in Shares) at Mar. 31, 2025                               955,552      
Stock-based compensation                               780 780
Issuance of common stock                               848 848
Issuance of common stock (in Shares)                                 171,750      
Net loss                               (3,225) (3,225)
Balance at Jun. 30, 2025                               $ 10 158,137 (156,510) 1,637
Balance (in Shares) at Jun. 30, 2025                               1,127,302      
Balance at Dec. 31, 2025                               $ 2,850 $ 10 160,058 (166,392) (3,474)
Balance (in Shares) at Dec. 31, 2025                               3,000 1,228,272      
Stock-based compensation                               11,869 11,869
Conversion of Series A preferred stock into common stock                               $ (186) 186
Conversion of Series A preferred stock into common stock (in Shares)                               (196) 50,007      
Transaction expense adjustments                               207 207
Series B preferred stock issued in connection with the Merger $ 2,576 $ 2,576                              
Series B preferred stock issued in connection with the Merger (in Shares) 241                                      
Series C preferred stock issued in connection with the Merger           $ 250,737 $ 250,737                    
Series C preferred stock issued in connection with the Merger (in Shares)           23,552                            
Series D preferred stock issued in connection with the Merger                     $ 323,732 $ 323,732          
Series D preferred stock issued in connection with the Merger (in Shares)                     30,227                  
Common stock issued upon conversion of Series B Preferred stock                               $ (2,576) 2,576
Common stock issued upon conversion of Series B Preferred stock (in Shares)                               (241) 240,544      
Issuance of common stock upon exercise of stock options                               464 464
Issuance of common stock upon exercise of stock options (in Shares)                                 504,650      
Par value adjustment for stock splits and stock dividend                               $ (10) 10
Issuance of replacement awards in connection with Merger                               4,910 4,910
Issuance of common stock from restricted stock units                              
Issuance of common stock from restricted stock units (in Shares)                                 37,165      
Shares cancelled                              
Shares cancelled (in Shares)                                 (453)      
Net loss                               (17,770) (17,770)
Balance at Jun. 30, 2026                               $ 577,133 180,280 (184,162) 573,251
Balance (in Shares) at Jun. 30, 2026                               56,583 2,060,185      
Balance at Mar. 31, 2026                               $ 577,319 170,125 (171,397) 576,047
Balance (in Shares) at Mar. 31, 2026                               56,779 1,921,809      
Stock-based compensation                               9,691 9,691
Conversion of Series A preferred stock into common stock                               $ (186) 186
Conversion of Series A preferred stock into common stock (in Shares)                               (196) 50,007      
Transaction expense adjustments                               207 207
Issuance of common stock upon exercise of stock options                               71 71
Issuance of common stock upon exercise of stock options (in Shares)                                 77,406      
Issuance of common stock from restricted stock units                              
Issuance of common stock from restricted stock units (in Shares)                                 11,416      
Shares cancelled                              
Shares cancelled (in Shares)                                 (453)      
Net loss                               (12,765) (12,765)
Balance at Jun. 30, 2026                               $ 577,133 $ 180,280 $ (184,162) $ 573,251
Balance (in Shares) at Jun. 30, 2026                               56,583 2,060,185